资金借道ETF加仓稀缺资产 聚焦电池、非银、创新药

Group 1 - The A-share market continues to experience fluctuations, with lithium battery materials seeing price increases, leading to a surge in lithium carbonate futures and related stocks [1] - The total net inflow of funds into ETFs reached 17.1 billion yuan on November 17, with about one-third of ETFs receiving additional investments [1] - The largest battery ETF (159755) saw a net inflow of 361 million yuan, increasing its total size to 16.29 billion yuan, making it the only battery-themed index fund over 10 billion yuan in size [1] Group 2 - The "lonely" Hong Kong Stock Connect non-bank ETF (513750) received a net inflow of 310 million yuan, reaching a new high of 25.8 billion yuan after 12 consecutive trading days of being favored by investors [2] - The largest Hong Kong innovative drug ETF (513120) also saw a net inflow of 57 million yuan, accumulating over 1.7 billion yuan in net inflows for November, with a total size of 25.4 billion yuan [2] - The combined size of two innovative drug ETFs managed by GF Fund has exceeded 30 billion yuan, making it the only fund manager with over 30 billion yuan in innovative drug-themed ETFs [2] Group 3 - The Shanghai Gold ETF (518600) recorded a net inflow of 145 million yuan, with a total size of 3.82 billion yuan and a year-to-date return of 49.71% [3] - Over the past three complete calendar years (2022-2024), the Shanghai Gold ETF has shown returns of 8.41%, 15.36%, and 26.63%, indicating strong defensive attributes [3] - The market sentiment indicators suggest a neutral zone, with potential opportunities for investors to adjust their positions towards a "barbell strategy," focusing on technology and defensive dividend sectors [3]